Rare Orbital Involvement Originating from Extranodal Marginal Zone Lymphoma

Medicina (Kaunas). 2024 Apr 25;60(5):706. doi: 10.3390/medicina60050706.

Abstract

Ocular adnexa region (OAR) primary lymphomas are uncommon, accounting for 1-2% of non-Hodgkin lymphomas and 8% of extranodal lymphomas. Extranodal marginal zone lymphoma (EMZL) originates from several epithelial tissues, including the stomach, salivary gland, lung, small intestine, thyroid gland, and ocular adnexa region. Here, we report a 66-year-old female patient who was diagnosed with EMZL of OAR. In consideration of the possible side effect of radiotherapy, such as conjunctivitis, visual acuity impairment, and even retinal complications, she received six cycles of triweekly targeted chemotherapy with rituximab, cyclophosphamide, vincristine, and prednisone (R-CVP) without radiotherapy. Then, she remained in complete remission up to the present day.

Keywords: extranodal marginal zone lymphoma; orbital lymphoma; orbital tumor.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Female
  • Humans
  • Lymphoma, B-Cell, Marginal Zone* / drug therapy
  • Orbital Neoplasms / drug therapy
  • Rituximab / therapeutic use

Substances

  • Rituximab

Grants and funding

This research received no external funding.